中文版 | English

在结果中检索

HFCAS OpenIR

浏览/检索结果: 共2条，第1-2条 帮助

限定条件    
已选(0)清除 条数/页：   排序方式：
Niraparib maintenance therapy in patients with platinum-sensitive recurrent ovarian cancer and a time-to-progression after penultimate platinum-based chemotherapy of 6-12 or > 12 months: a subgroup analysis of the phase III NORA trial 期刊论文
GYNECOLOGIC ONCOLOGY, 2021, 卷号: 162
作者:  Huang, Qidan;  Wu, Xiaohua;  Zhu, Jianqing;  Wang, Danqing;  Yang, Jiaxin;  Wang, Jing;  Wu, Lingying;  Liu, Ziling;  Gao, Yunong;  Wang, Danbo;  Lou, Ge;  Yang, Hongying;  Zhou, Qi;  Kong, Beihua;  Huang, Yi;  Chen, Lipai;  Li, Guiling;  An, Ruifang;  Wang, Ke;  Zhang, Yu;  Yan, Xiaojian;  Lu, Xin;  Wang, Li;  Tan, Tao;  Dong, Juan
收藏  |  浏览/下载：57/0  |  提交时间：2021/11/01
Efficacy and safety of niraparib maintenance therapy in patients with platinum-sensitive recurrent ovarian cancer with complete or partial response to the last platinum-based chemotherapy: a subgroup analysis of the phase III NORA trial 期刊论文
GYNECOLOGIC ONCOLOGY, 2021, 卷号: 162
作者:  Yang, Jiaxin;  Wu, Xiaohua;  Zhu, Jianqing;  Song, Liang;  Feng, Yanling;  Wang, Jing;  Wu, Lingying;  Liu, Ziling;  Gao, Yunong;  Wang, Danbo;  Lou, Ge;  Yang, Hongying;  Zhou, Qi;  Kong, Beihua;  Huang, Yi;  Chen, Lipai;  Li, Guiling;  An, Ruifang;  Wang, Ke;  Zhang, Yu;  Yan, Xiaojian;  Lu, Xin;  Wang, Li;  Tan, Tao;  Dong, Juan
收藏  |  浏览/下载：66/0  |  提交时间：2021/11/01